(Washington, DC – April 27, 2016) –  Galileo Analytics Co-Founder Anna McCollister-Slipp will join FDA Commissioner Robert Califf and informatics leaders from IBM, NIH and the Brookings Institution next week on a featured panel at the 26th Annual Society for Women’s Health Research gala in Washington, DC.

This year’s gala is focused on the potential for digital health tools and electronic health data to revolutionize health care and health research.

In addition to McCollister-Slipp and Califf, the panel discussion will include Kavita Patel, MD, Senior Fellow at the Brookings Institution, Jennie Larkin, PhD, Senior Advisor for Extramural Programs and Strategic Planning at the NIH and Jane L. Snowdon, PhD,  Director, Watson Health Partnerships, IBM.

The evening will also include keynote presentations from Alyson McGregor, MD, Associate Professor of Emergency Medicine at Brown University and David Page, MD, Director of the Whitehead Institute, Professor of Biology at Massachusetts Institute of Technology and Investigator at the Howard Hughes Medical Institute.

For more information on the 26th Annual Society for Women’s Health Research gala visit www.SWHR.org.

About SWHR

The Society for Women’s Health Research (SWHR®), is a national nonprofit based in Washington D.C. that is widely recognized as the thought-leader in promoting research on biological differences in disease and is dedicated to transforming women’s health through science, advocacy, and education. Founded in 1990 by a group of physicians, medical researchers and health advocates, SWHR aims to bring attention to the variety of diseases and conditions that disproportionately or predominately affect women.

Admin

About Admin

Anna McCollister-Slipp is co-founder of Galileo Analytics, a Visual Data Exploration and advanced data analytics company focused on democratizing access to and understanding of complex health data. In addition, she is the Chief Advocate for Participatory Research at the Scripps Translational Science Institute, where she is charged with bringing the expertise of patients, caregivers and community physicians into the design of health research. Anna’s passion for innovation in health data research is rooted in her personal experiences living with type 1 diabetes. As an entrepreneur and advocate, she speaks frequently about the promise of digital health, the imperative for patient data access and the need for improved outcomes measures for chronic disease. Anna serves on a number of government and private committees and boards aimed at promoting innovative ways to better understand, manage and treat complex health conditions, such as diabetes.

%d bloggers like this: